Focal segmental glomerulosclerosis.
D'Agati VD, Kaskel FJ, Falk RJ.
N Engl J Med. 2011 Dec 22;365(25):2398-411. doi: 10.1056/NEJMra1106556.
Focal Segmental Glomerulosclerosis: State-of-the-Art and Clinical Perspective.
Shabaka A, Tato Ribera A, Fernández-Juárez G.
Nephron. 2020;144(9):413-427. doi: 10.1159/000508099. Epub 2020 Jul 28.
Causes and pathogenesis of focal segmental glomerulosclerosis.
Fogo AB.
Nat Rev Nephrol. 2015 Feb;11(2):76-87. doi: 10.1038/nrneph.2014.216. Epub 2014 Dec 2.
Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders.
Altintas MM, Agarwal S, Sudhini Y, Zhu K, Wei C, Reiser J.
Annu Rev Pathol. 2025 Jan;20(1):329-353. doi: 10.1146/annurev-pathol-051220-092001.
Efficacy of combined rituximab and daratumumab treatment in posttransplant recurrent focal segmental glomerulosclerosis.
Angeletti A, Bin S, Magnasco A, Bruschi M, Cravedi P, Ghiggeri GM.
Am J Transplant. 2024 Apr;24(4):688-692. doi: 10.1016/j.ajt.2023.12.010. Epub 2023 Dec 14.
Podocytopathies.
Navarro-Torres M, Wooden B, Santoriello D, Radhakrishnan J, Bomback AS.
Adv Kidney Dis Health. 2025 Jan;32(1):2-11. doi: 10.1053/j.akdh.2024.10.004.
Are all patients with idiopathic focal segmental glomerulosclerosis (FSGS) created equal?
Cattran DC.
Nephrol Dial Transplant. 1998 May;13(5):1107-9. doi: 10.1093/ndt/13.5.1107.
Potential biomarkers of recurrent FSGS: a review.
Hou S, Yang B, Chen Q, Xu Y, Li H.
BMC Nephrol. 2024 Aug 12;25(1):258. doi: 10.1186/s12882-024-03695-8.
Focal segmental glomerulosclerosis.
Goldszer RC, Sweet J, Cotran RS.
Annu Rev Med. 1984;35:429-49. doi: 10.1146/annurev.me.35.020184.002241.
Slit Diaphragms: Junctions That Never Sleep.
Drummond IA.
J Am Soc Nephrol. 2022 Dec;33(12):2127-2128. doi: 10.1681/ASN.2022101147. Epub 2022 Nov 4.
